The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Lymphedema Diagnostics-Global Market Insights and Sales Trends 2024
Synopsis
The global Lymphedema Diagnostics market size is expected to reach US$ 39 million by 2029, growing at a CAGR of 5.4% from 2023 to 2029. The market is mainly driven by the significant applications of Lymphedema Diagnostics in various end use industries. The expanding demands from the Cancer, Inflammatory Diseases, Cardiovascular Disease and Other, are propelling Lymphedema Diagnostics market. Lymphoscintigraphy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Magnetic Resonance Imaging segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Lymphedema Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Lymphedema Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Lymphedema Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Lymphedema Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Lymphedema Diagnostics covered in this report include GE Healthcare, Siemens Healthineers (A Subsidiary of Siemens Group), Philips, Canon, Inc., Shimadzu Corporation, Stryker Corporation, Fluoptics, United Imaging Healthcare Co., Ltd. and Hitachi, Ltd., etc.
The global Lymphedema Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GE Healthcare
Siemens Healthineers (A Subsidiary of Siemens Group)
Philips
Canon, Inc.
Shimadzu Corporation
Stryker Corporation
Fluoptics
United Imaging Healthcare Co., Ltd.
Hitachi, Ltd.
Esaote SPA
Neusoft Corporation
Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.)
Mitaka Usa, Inc.
Curadel, LLC
Impedimed Limited
Global Lymphedema Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Lymphedema Diagnostics market, Segment by Type:
Lymphoscintigraphy
Magnetic Resonance Imaging
Ultrasound Imaging
Computed Tomography
X-Ray Lymphography
Bioimpedance Analysis
Near-Infrared Fluorescence Imaging
Global Lymphedema Diagnostics market, by Application
Cancer
Inflammatory Diseases
Cardiovascular Disease
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Lymphedema Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Lymphedema Diagnostics market size is expected to reach US$ 39 million by 2029, growing at a CAGR of 5.4% from 2023 to 2029. The market is mainly driven by the significant applications of Lymphedema Diagnostics in various end use industries. The expanding demands from the Cancer, Inflammatory Diseases, Cardiovascular Disease and Other, are propelling Lymphedema Diagnostics market. Lymphoscintigraphy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Magnetic Resonance Imaging segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Lymphedema Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Lymphedema Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Lymphedema Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Lymphedema Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Lymphedema Diagnostics covered in this report include GE Healthcare, Siemens Healthineers (A Subsidiary of Siemens Group), Philips, Canon, Inc., Shimadzu Corporation, Stryker Corporation, Fluoptics, United Imaging Healthcare Co., Ltd. and Hitachi, Ltd., etc.
The global Lymphedema Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GE Healthcare
Siemens Healthineers (A Subsidiary of Siemens Group)
Philips
Canon, Inc.
Shimadzu Corporation
Stryker Corporation
Fluoptics
United Imaging Healthcare Co., Ltd.
Hitachi, Ltd.
Esaote SPA
Neusoft Corporation
Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.)
Mitaka Usa, Inc.
Curadel, LLC
Impedimed Limited
Global Lymphedema Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Lymphedema Diagnostics market, Segment by Type:
Lymphoscintigraphy
Magnetic Resonance Imaging
Ultrasound Imaging
Computed Tomography
X-Ray Lymphography
Bioimpedance Analysis
Near-Infrared Fluorescence Imaging
Global Lymphedema Diagnostics market, by Application
Cancer
Inflammatory Diseases
Cardiovascular Disease
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Lymphedema Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Lymphedema Diagnostics
1.1 Lymphedema Diagnostics Market Overview
1.1.1 Lymphedema Diagnostics Product Scope
1.1.2 Lymphedema Diagnostics Market Status and Outlook
1.2 Global Lymphedema Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Lymphedema Diagnostics Market Size by Region (2018-2029)
1.4 Global Lymphedema Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Lymphedema Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Lymphedema Diagnostics Market Size (2018-2029)
1.6.1 North America Lymphedema Diagnostics Market Size (2018-2029)
1.6.2 Europe Lymphedema Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Lymphedema Diagnostics Market Size (2018-2029)
1.6.4 Latin America Lymphedema Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Lymphedema Diagnostics Market Size (2018-2029)
2 Lymphedema Diagnostics Market by Type
2.1 Introduction
2.1.1 Lymphoscintigraphy
2.1.2 Magnetic Resonance Imaging
2.1.3 Ultrasound Imaging
2.1.4 Computed Tomography
2.1.5 X-Ray Lymphography
2.1.6 Bioimpedance Analysis
2.1.7 Near-Infrared Fluorescence Imaging
2.2 Global Lymphedema Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Lymphedema Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Lymphedema Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Lymphedema Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Lymphedema Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Lymphedema Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Lymphedema Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Lymphedema Diagnostics Revenue Breakdown by Type (2018-2029)
3 Lymphedema Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Cancer
3.1.2 Inflammatory Diseases
3.1.3 Cardiovascular Disease
3.1.4 Other
3.2 Global Lymphedema Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Lymphedema Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Lymphedema Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Lymphedema Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Lymphedema Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Lymphedema Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Lymphedema Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Lymphedema Diagnostics Revenue Breakdown by Application (2018-2029)
4 Lymphedema Diagnostics Competition Analysis by Players
4.1 Global Lymphedema Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lymphedema Diagnostics as of 2022)
4.3 Date of Key Players Enter into Lymphedema Diagnostics Market
4.4 Global Top Players Lymphedema Diagnostics Headquarters and Area Served
4.5 Key Players Lymphedema Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Lymphedema Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GE Healthcare
5.1.1 GE Healthcare Profile
5.1.2 GE Healthcare Main Business
5.1.3 GE Healthcare Lymphedema Diagnostics Products, Services and Solutions
5.1.4 GE Healthcare Lymphedema Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 GE Healthcare Recent Developments
5.2 Siemens Healthineers (A Subsidiary of Siemens Group)
5.2.1 Siemens Healthineers (A Subsidiary of Siemens Group) Profile
5.2.2 Siemens Healthineers (A Subsidiary of Siemens Group) Main Business
5.2.3 Siemens Healthineers (A Subsidiary of Siemens Group) Lymphedema Diagnostics Products, Services and Solutions
5.2.4 Siemens Healthineers (A Subsidiary of Siemens Group) Lymphedema Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Siemens Healthineers (A Subsidiary of Siemens Group) Recent Developments
5.3 Philips
5.3.1 Philips Profile
5.3.2 Philips Main Business
5.3.3 Philips Lymphedema Diagnostics Products, Services and Solutions
5.3.4 Philips Lymphedema Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Canon, Inc. Recent Developments
5.4 Canon, Inc.
5.4.1 Canon, Inc. Profile
5.4.2 Canon, Inc. Main Business
5.4.3 Canon, Inc. Lymphedema Diagnostics Products, Services and Solutions
5.4.4 Canon, Inc. Lymphedema Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Canon, Inc. Recent Developments
5.5 Shimadzu Corporation
5.5.1 Shimadzu Corporation Profile
5.5.2 Shimadzu Corporation Main Business
5.5.3 Shimadzu Corporation Lymphedema Diagnostics Products, Services and Solutions
5.5.4 Shimadzu Corporation Lymphedema Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Shimadzu Corporation Recent Developments
5.6 Stryker Corporation
5.6.1 Stryker Corporation Profile
5.6.2 Stryker Corporation Main Business
5.6.3 Stryker Corporation Lymphedema Diagnostics Products, Services and Solutions
5.6.4 Stryker Corporation Lymphedema Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Stryker Corporation Recent Developments
5.7 Fluoptics
5.7.1 Fluoptics Profile
5.7.2 Fluoptics Main Business
5.7.3 Fluoptics Lymphedema Diagnostics Products, Services and Solutions
5.7.4 Fluoptics Lymphedema Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Fluoptics Recent Developments
5.8 United Imaging Healthcare Co., Ltd.
5.8.1 United Imaging Healthcare Co., Ltd. Profile
5.8.2 United Imaging Healthcare Co., Ltd. Main Business
5.8.3 United Imaging Healthcare Co., Ltd. Lymphedema Diagnostics Products, Services and Solutions
5.8.4 United Imaging Healthcare Co., Ltd. Lymphedema Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 United Imaging Healthcare Co., Ltd. Recent Developments
5.9 Hitachi, Ltd.
5.9.1 Hitachi, Ltd. Profile
5.9.2 Hitachi, Ltd. Main Business
5.9.3 Hitachi, Ltd. Lymphedema Diagnostics Products, Services and Solutions
5.9.4 Hitachi, Ltd. Lymphedema Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 Hitachi, Ltd. Recent Developments
5.10 Esaote SPA
5.10.1 Esaote SPA Profile
5.10.2 Esaote SPA Main Business
5.10.3 Esaote SPA Lymphedema Diagnostics Products, Services and Solutions
5.10.4 Esaote SPA Lymphedema Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 Esaote SPA Recent Developments
5.11 Neusoft Corporation
5.11.1 Neusoft Corporation Profile
5.11.2 Neusoft Corporation Main Business
5.11.3 Neusoft Corporation Lymphedema Diagnostics Products, Services and Solutions
5.11.4 Neusoft Corporation Lymphedema Diagnostics Revenue (US$ Million) & (2018-2023)
5.11.5 Neusoft Corporation Recent Developments
5.12 Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.)
5.12.1 Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Profile
5.12.2 Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Main Business
5.12.3 Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Lymphedema Diagnostics Products, Services and Solutions
5.12.4 Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Lymphedema Diagnostics Revenue (US$ Million) & (2018-2023)
5.12.5 Mindray Medical International Limited (A Subsidiary of Excelsior Union, Ltd.) Recent Developments
5.13 Mitaka Usa, Inc.
5.13.1 Mitaka Usa, Inc. Profile
5.13.2 Mitaka Usa, Inc. Main Business
5.13.3 Mitaka Usa, Inc. Lymphedema Diagnostics Products, Services and Solutions
5.13.4 Mitaka Usa, Inc. Lymphedema Diagnostics Revenue (US$ Million) & (2018-2023)
5.13.5 Mitaka Usa, Inc. Recent Developments
5.14 Curadel, LLC
5.14.1 Curadel, LLC Profile
5.14.2 Curadel, LLC Main Business
5.14.3 Curadel, LLC Lymphedema Diagnostics Products, Services and Solutions
5.14.4 Curadel, LLC Lymphedema Diagnostics Revenue (US$ Million) & (2018-2023)
5.14.5 Curadel, LLC Recent Developments
5.15 Impedimed Limited
5.15.1 Impedimed Limited Profile
5.15.2 Impedimed Limited Main Business
5.15.3 Impedimed Limited Lymphedema Diagnostics Products, Services and Solutions
5.15.4 Impedimed Limited Lymphedema Diagnostics Revenue (US$ Million) & (2018-2023)
5.15.5 Impedimed Limited Recent Developments
6 North America
6.1 North America Lymphedema Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Lymphedema Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Lymphedema Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Lymphedema Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Lymphedema Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Lymphedema Diagnostics Market Dynamics
11.1 Lymphedema Diagnostics Industry Trends
11.2 Lymphedema Diagnostics Market Drivers
11.3 Lymphedema Diagnostics Market Challenges
11.4 Lymphedema Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
